• Something wrong with this record ?

Polymorphous Sweat Gland Carcinoma: An Immunohistochemical and Molecular Study

S. Ronen, I. Aguilera-Barrantes, T. Giorgadze, P. Šteiner, P. Grossmann, S. Suster,

. 2018 ; 40 (8) : 580-587.

Language English Country United States

Document type Journal Article

Persistent link   https://www.medvik.cz/link/bmc19000872

Polymorphous sweat gland carcinoma is an uncommon low-grade malignant adnexal tumor with a marked predilection for the distal extremities. Histologically, the lesions are characterized by a cellular proliferation showing a combination of growth patterns, including trabecular, solid, tubular, cribriform, or adenoid cystic and pseudopapillary. The immunohistochemical and molecular profile of these tumors has not yet been properly addressed. We have studied 3 cases of polymorphous sweat gland carcinoma using a broad panel of immunohistochemical markers including cytokeratin AE1/AE3, CK5/6, MOC31, p40, p63, p16, chromogranin, synaptophysin, CD56, MIB-1, estrogen receptor, progesterone receptor, androgen receptor, BER-EP4, smooth muscle actin, epithelial membrane antigen, carcinoembryonic antigen, CD117, S100 protein, HBME-1, DOG1, vimentin, and mammaglobin. We also examined for the MYB-NFIB fusion by fluorescent in situ hybridization (ISH) and for human papilloma virus by ISH. Our studies show that cytokeratin AE1/AE3, CK5/6, p40, p63, p16, chromogranin, and CD56 stains were positive in all 3 cases. All 3 cases were negative for MYB-NFIB fusion by fluorescent ISH which rules out adenoid cystic carcinoma. DNA ISH studies for high-risk human papilloma virus were negative in all cases. MIB-1 proliferation index was very high (30%-70% nuclear positivity), supporting a malignant phenotype. The positivity for chromogranin and CD56 suggests partial neuroendocrine differentiation. The differential diagnosis includes metastases from internal malignancies, basal cell carcinoma, and other benign and malignant adnexal neoplasms such as adenoid cystic carcinoma, ductal eccrine carcinoma, and microcystic carcinoma. Positivity for p16 in combination with chromogranin and CD56 may be potentially good markers for differentiating this tumor from other adnexal tumors.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc19000872
003      
CZ-PrNML
005      
20190121110345.0
007      
ta
008      
190107s2018 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1097/DAD.0000000000001128 $2 doi
035    __
$a (PubMed)29533280
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Ronen, Shira $u Department of Pathology, Medical College of Wisconsin, Milwaukee, WI.
245    10
$a Polymorphous Sweat Gland Carcinoma: An Immunohistochemical and Molecular Study / $c S. Ronen, I. Aguilera-Barrantes, T. Giorgadze, P. Šteiner, P. Grossmann, S. Suster,
520    9_
$a Polymorphous sweat gland carcinoma is an uncommon low-grade malignant adnexal tumor with a marked predilection for the distal extremities. Histologically, the lesions are characterized by a cellular proliferation showing a combination of growth patterns, including trabecular, solid, tubular, cribriform, or adenoid cystic and pseudopapillary. The immunohistochemical and molecular profile of these tumors has not yet been properly addressed. We have studied 3 cases of polymorphous sweat gland carcinoma using a broad panel of immunohistochemical markers including cytokeratin AE1/AE3, CK5/6, MOC31, p40, p63, p16, chromogranin, synaptophysin, CD56, MIB-1, estrogen receptor, progesterone receptor, androgen receptor, BER-EP4, smooth muscle actin, epithelial membrane antigen, carcinoembryonic antigen, CD117, S100 protein, HBME-1, DOG1, vimentin, and mammaglobin. We also examined for the MYB-NFIB fusion by fluorescent in situ hybridization (ISH) and for human papilloma virus by ISH. Our studies show that cytokeratin AE1/AE3, CK5/6, p40, p63, p16, chromogranin, and CD56 stains were positive in all 3 cases. All 3 cases were negative for MYB-NFIB fusion by fluorescent ISH which rules out adenoid cystic carcinoma. DNA ISH studies for high-risk human papilloma virus were negative in all cases. MIB-1 proliferation index was very high (30%-70% nuclear positivity), supporting a malignant phenotype. The positivity for chromogranin and CD56 suggests partial neuroendocrine differentiation. The differential diagnosis includes metastases from internal malignancies, basal cell carcinoma, and other benign and malignant adnexal neoplasms such as adenoid cystic carcinoma, ductal eccrine carcinoma, and microcystic carcinoma. Positivity for p16 in combination with chromogranin and CD56 may be potentially good markers for differentiating this tumor from other adnexal tumors.
650    _2
$a senioři $7 D000368
650    _2
$a nádorové biomarkery $x analýza $7 D014408
650    _2
$a karcinom kožních adnex $x diagnóza $x patologie $7 D018280
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a lidé $7 D006801
650    _2
$a imunohistochemie $7 D007150
650    _2
$a hybridizace in situ fluorescenční $7 D017404
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a lidé středního věku $7 D008875
650    _2
$a nádory potních žláz $x diagnóza $x patologie $7 D013544
655    _2
$a časopisecké články $7 D016428
700    1_
$a Aguilera-Barrantes, Irene $u Department of Pathology, Medical College of Wisconsin, Milwaukee, WI.
700    1_
$a Giorgadze, Tamara $u Department of Pathology, Medical College of Wisconsin, Milwaukee, WI.
700    1_
$a Šteiner, Petr $u Bioptic Laboratory Ltd, Molecular Pathology Laboratory, Plzen, Czech Republic. Department of Pathology, Faculty of Medicine, Charles University, Pilsen, Czech Republic.
700    1_
$a Grossmann, Petr $u Bioptic Laboratory Ltd, Molecular Pathology Laboratory, Plzen, Czech Republic.
700    1_
$a Suster, Saul $u Department of Pathology, Medical College of Wisconsin, Milwaukee, WI.
773    0_
$w MED00000240 $t The American Journal of dermatopathology $x 1533-0311 $g Roč. 40, č. 8 (2018), s. 580-587
856    41
$u https://pubmed.ncbi.nlm.nih.gov/29533280 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20190107 $b ABA008
991    __
$a 20190121110603 $b ABA008
999    __
$a ok $b bmc $g 1363940 $s 1038995
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2018 $b 40 $c 8 $d 580-587 $i 1533-0311 $m The American journal of dermatopathology $n Am J Dermatopathol $x MED00000240
LZP    __
$a Pubmed-20190107

Find record

Citation metrics

Archiving options